ARCHIVES

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

This article is from The Cancer Letter archive.

Vol. 02 No. 47 | November 19, 1976

Download PDF Visit The Full Archive

Related Articles

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

July 3, 1992

Cooperative Group Chairman Unhappy Over Exclusion From Funding at Recommended Levels

December 2, 1983

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

November 29, 2002

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

February 2, 1979